Anti-CD70 Chimeric Antigen Receptors
European Patent
22164990.8
Filed on 2022-03-29
22164990.8
Filed on 2022-03-29
COMPOSITIONS AND METHODS FOR TREATING CANCER
Patent Cooperation Treaty
PCT/US2021/062832
Filed on 2021-12-10
PCT/US2021/062832
Filed on 2021-12-10
METHODS OF ISOLATING T CELL POPULATIONS
European Patent
20786149.3
Filed on 2020-09-18
20786149.3
Filed on 2020-09-18
METHODS OF ISOLATING T CELL POPULATIONS
US Application 17/636,206
Filed on 2022-02-17
Filed on 2022-02-17
METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR
REACTIVE T CELLS FROM PERIPHERAL BLOOD
Japan
2022-011975
Filed on 2022-01-28
2022-011975
Filed on 2022-01-28
CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer
Australia
2022200267
Filed on 2022-01-17
2022200267
Filed on 2022-01-17
RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER
US Application 17/692,978
Filed on 2022-03-11
Filed on 2022-03-11
RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER
European Patent
20785624.6
Filed on 2020-09-11
20785624.6
Filed on 2020-09-11
RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER
Canada
3153096
Filed on 2020-09-11
3153096
Filed on 2020-09-11
Glypican 2 As A Cancer Marker And Therapeutic Target
Japan
2021-194050
Filed on 2016-11-08
2021-194050
Filed on 2016-11-08